LRIG2 and central nervous system cancer: LRIG2 belongs to the leucine-rich repeats and immunoglobulin-like domains family and regulates epidermal growth factor receptor (EGFR) signaling pathway (Simion et al., 2014), and downregulation of LRIG2 suppressed angiogenesis in glioma (Yang et al., 2017).